The Rundown cover image

Eli Lilly Bets Billions on AI Drugs From China, Private Credit Panic Grows

The Rundown

00:00

Eli Lilly's $2.75B AI drug deal

Zaid explains Lilly's Insilico partnership, deal terms, and China's fast AI-driven drug progress.

Play episode from 05:35
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app